These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27388992)

  • 1. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita.
    Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ
    J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Remington J; Chen M; Burnett J; Woodley DT
    Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita.
    Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J
    Front Immunol; 2019; 10():3012. PubMed ID: 31993051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita.
    Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K
    Front Immunol; 2024; 15():1343299. PubMed ID: 38799441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita.
    Tukaj S; Bieber K; Witte M; Ghorbanalipoor S; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    J Invest Dermatol; 2018 Feb; 138(2):301-309. PubMed ID: 28942362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
    Hellberg L; Samavedam UKSRL; Holdorf K; Hänsel M; Recke A; Beckmann T; Steinhorst K; Boehncke WH; Kirchner T; Möckel N; Solbach W; Zillikens D; Schmidt E; Ludwig RJ; Laskay T
    J Invest Dermatol; 2013 Oct; 133(10):2390-2399. PubMed ID: 23448878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme B inhibition reduces autoantibody-induced dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita.
    Emtenani S; Lebhar H; Marquis CP; Ludwig RJ; Schmidt E
    Exp Dermatol; 2024 Sep; 33(9):e15172. PubMed ID: 39219105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
    Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
    J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
    Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
    J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
    Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
    J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
    Ludwig R
    Expert Rev Clin Immunol; 2015; 11(12):1365-78. PubMed ID: 26471717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models of epidermolysis bullosa acquisita.
    Sitaru C
    Exp Dermatol; 2007 Jun; 16(6):520-31. PubMed ID: 17518993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
    Akbarzadeh R; Yu X; Vogl T; Ludwig RJ; Schmidt E; Zillikens D; Petersen F
    J Dermatol Sci; 2016 Mar; 81(3):165-72. PubMed ID: 26692467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa acquisita.
    Cobos G; Mu E; Cohen J; Beasley J; Brinster N; Femia A
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
    Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
    Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita.
    Samavedam UK; Iwata H; Müller S; Schulze FS; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    J Immunol; 2014 Jan; 192(2):559-71. PubMed ID: 24337383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.